Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical utility of a Bayesian dosing program for phenytoin.

M D Privitera1, R W Homan, T M Ludden

  • 1Department of Neurology, Veterans Administration Medical Center, Dallas, Texas.

Therapeutic Drug Monitoring
|January 1, 1989
PubMed
Summary

A new computer program using Bayesian regression analysis improved phenytoin (PHT) dosing accuracy compared to physicians. This PHT dosing tool also accurately predicted serum concentrations in patients experiencing toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lay descriptions of painful temporomandibular disorders-an international consensus proposal for Global Burden of Disease estimates.

BMC medicine·2026
Same author

Response to Letter to Editor: "Disability Weights for Global Burden Estimation of Orofacial Pain".

Journal of dental research·2026
Same author

Disability Weights for Global Burden Estimation of Orofacial Pain.

Journal of dental research·2025
Same author

Altered regional brain T2 relaxation times in individuals with chronic orofacial neuropathic pain.

NeuroImage. Clinical·2018
Same author

Disruption of default mode network dynamics in acute and chronic pain states.

NeuroImage. Clinical·2017
Same author

Self-management programmes in temporomandibular disorders: results from an international Delphi process.

Journal of oral rehabilitation·2016

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Computational Medicine

Background:

  • Phenytoin (PHT) is a widely used antiepileptic drug.
  • Accurate PHT dosing is crucial for therapeutic efficacy and minimizing toxicity.
  • Current dosing methods can be imprecise, especially with non-steady-state concentrations.

Purpose of the Study:

  • To evaluate the clinical utility of a Bayesian regression analysis computer program for phenytoin (PHT) dosing.
  • To compare the accuracy and bias of the PHT dosing program against physician dosing.
  • To assess the program's ability to predict PHT serum concentrations in patients with toxicity.

Main Methods:

  • A randomized prospective study involving 40 epileptic patients compared physician dosing to the PHT dosing program.

Related Experiment Videos

  • A second study analyzed the program's predictive accuracy for 91 serum concentrations in 31 patients with PHT toxicity.
  • Bayesian regression analysis formed the core of the computer dosing program.

    • Main Results:

    • The PHT dosing program demonstrated significantly higher accuracy (p = 0.002) and less bias (p = 0.02) than physicians.
    • Physician dosing errors were largest with non-steady-state PHT concentrations, but the program's accuracy was unaffected.
    • The program predicted PHT serum concentrations in toxicity cases with a mean error of 3.49 +/- 0.29 µg/ml, showing no over- or underprediction bias.

    Conclusions:

    • The Bayesian regression analysis program shows significant clinical utility in improving PHT dosing accuracy.
    • The PHT dosing program can aid clinicians by enhancing therapeutic drug monitoring.
    • The tool is effective in predicting PHT serum concentrations, particularly in cases of toxicity.